Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05900193 · ClinicalTrials.gov registry record · NA
Sucralose and Lactisole Additions to OGTT in Humans
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05900193 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 19 participants.
The verdict
NCT05900193, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
In the present study, our objective was to determine whether T1R2-T1R3 influences glucose metabolism bidirectionally via hyperactivation with sucralose and inhibition with sodium lactisole in mixture with glucose loads during tolerance tests in humans. In 12 healthy participants we conducted oral glucose tolerance tests (OGTTs) of 75 g glucose with and without the addition of the T1R2-T1R3 agonist, sucralose (5 mM). We also conducted OGTTs in 10 healthy participants with and without the addition of a T1R2-T1R3 antagonist, sodium lactisole (2 mM). Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants' sweet taste responses to sucralose, their sensitivities to sweetness inhibition by lactisole, and their BMIs.
Interventions
- DIETARY_SUPPLEMENT TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-07-17 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05900193
The ClinicalTrials.gov registry entry for NCT05900193 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test is the first listed.
NCT05900193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05900193 about?
NCT05900193 is a clinical study titled "Sucralose and Lactisole Additions to OGTT in Humans". In the present study, our objective was to determine whether T1R2-T1R3 influences glucose metabolism bidirectionally via hyperactivation with sucralose and inhibition with sodium lactisole in mixture with glucose loads during tolerance tests in humans. In 12 healthy participants we conducted oral gl...
What is the current status of trial NCT05900193?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2016-07-17. Estimated completion is 2017-10.
What interventions are being tested in trial NCT05900193?
The interventions under investigation include: TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05900193?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.